Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 22 Apr 2025 for UNITED THERAPEUTICS Corp, €457k. Read the official filing
Filing timeline
BuySaleRaymond Dwek
Insider track record
Disclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Raymond Dwek: trading record in brief
All filings by Raymond Dwek on record concern UNITED THERAPEUTICS Corp, in the capacity of senior executive. We count 33 filings; the first trade dates from 7 January 2016 and the latest from 21 April 2025.
Every open-market trade on record is a sale: 8 sales worth €1.2M. No amount is published for 6 filings, which the totals therefore leave out. Outside the open market, there are 25 option exercises. Since January 2025: no purchases and 1 sale on the market.
On 22 April 2025 came the latest disclosure, an option exercise for €457k in UNITED THERAPEUTICS Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Raymond Dwek
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations33 total
3,000 shares@ US$175.436.5% of flowCommon StockSEC:0001562180-25-003225:0
3,000 shares@ US$285.5710.5% of flowCommon StockSEC:0001562180-25-003225:1
3,000 shares@ US$175.436.6% of flowCommon StockSEC:0001562180-25-003157:0
4,000 shares@ US$175.439.1% of flowCommon StockSEC:0001562180-25-003069:0
5,000 shares@ US$175.4311.5% of flowCommon StockSEC:0001415889-24-020750:0
3,000 shares@ US$88.033.5% of flowCommon StockSEC:0001415889-24-011371:0
3,000 shares@ US$88.033.5% of flowCommon StockSEC:0001415889-24-010867:0
4,000 shares@ US$88.034.6% of flowCommon StockSEC:0001415889-24-010572:0
1,750 shares0Common StockSEC:0001415889-23-010946:0
2,000 shares@ US$63.901.6% of flowCommon StockSEC:0001415889-23-006806:0
2,000 shares@ US$63.901.6% of flowCommon StockSEC:0001415889-23-006615:0
3,000 shares@ US$63.902.5% of flowCommon StockSEC:0001415889-23-006472:0
5,000 shares@ US$88.036.3% of flowCommon StockSEC:0001415889-22-011178:0
3,000 shares@ US$63.902.7% of flowCommon StockSEC:0001415889-22-009534:0
2,160 shares0Common StockSEC:0001415889-22-007625:0
5,000 shares@ US$63.900.0012% mcap14.3% of flowCommon StockSEC:0001415889-22-005734:0
2,000 shares@ US$48.110.0004% mcap4.4% of flowCommon StockSEC:0001415889-22-004706:0
2,000 shares@ US$48.110.0004% mcap4.4% of flowCommon StockSEC:0001415889-22-004365:0
2,000 shares@ US$48.110.0004% mcap4.3% of flowCommon StockSEC:0001415889-22-004229:0
2,000 shares@ US$48.110.0004% mcap4.3% of flowCommon StockSEC:0001415889-22-004084:0
2,000 shares@ US$48.110.0004% mcap4.3% of flowCommon StockSEC:0001415889-22-003959:0
3,000 shares@ US$48.111.9% of flowCommon StockSEC:0001127602-21-028625:0
3,360 shares@ US$176.017.7% of flowCommon StockSEC:0001127602-21-020861:0
3,360 shares0Common StockSEC:0001127602-21-020803:0
2,000 shares@ US$54.771.4% of flowCommon StockSEC:0001127602-21-015745:0
25 of 33 declarations
